Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.14 | 0.17 | 0.03 |
Stocks | 97.94 | 97.94 | 0.00 |
Other | 1.92 | 2.06 | 0.14 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.15 | 20.48 |
Price to Book | 4.97 | 4.65 |
Price to Sales | 6.87 | 2.71 |
Price to Cash Flow | 20.00 | 18.41 |
Dividend Yield | 0.83 | 1.04 |
5 Years Earnings Growth | 31.24 | 16.41 |
Number of long holdings: 206
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 10.33 | 181.14 | +2.30% | |
Amgen | US0311621009 | 9.33 | 280.01 | -4.76% | |
Krystal Biotech | US5011471027 | 6.90 | 196.52 | +1.01% | |
Regeneron Pharma | US75886F1075 | 4.38 | 753.03 | +0.47% | |
Vertex | US92532F1003 | 4.18 | 467.12 | +1.17% | |
Alnylam | US02043Q1076 | 3.65 | 253.29 | +0.92% | |
Gilead | US3755581036 | 2.81 | 91.35 | +0.95% | |
Vaxcyte | US92243G1085 | 2.18 | 91.45 | -0.27% | |
Ascendis Pharma AS | US04351P1012 | 1.99 | 134.60 | +2.87% | |
UCB | BE0003739530 | 1.97 | 182.25 | -1.06% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 592.67B | 20.96 | 9.07 | 12.99 | ||
Fidelity Contrafund | 128.94B | 30.86 | 9.80 | 15.03 | ||
Fidelity Contrafund K | 128.94B | 30.89 | 9.88 | 15.12 | ||
Fidelity Total Market Index Instl b | 100.61B | 19.75 | 7.53 | 12.38 | ||
Fidelity Blue Chip Growth | 62.16B | 28.77 | 6.99 | 17.42 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review